Juan Esteban Ferrario

Juan Esteban Ferrario

Auto-generated profile, based on publicly available information

Juan Esteban Ferrario

Instituto de Investigaciones Farmacológicas (ININFA), UBA-CONICET, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Cell Reports
Verified
Journal Article
Open access
SESonia Lorena Espíndola
Sonia Lorena Espíndola
ADAna Damianich
Ana Damianich
RARodrigo Javier Alvarez
Rodrigo Javier Alvarez
MSManuela Sartor
Manuela Sartor
JBJuan Emilio Belforte
Juan Emilio Belforte
MAMaría Elena Avale
María Elena Avale
The microtubule-associated protein tau regulates myriad neuronal functions, such as microtubule dynamics, axonal transport and neurite outgrowth. Tauopathies are neurodegenerative disorders characterized by the abnormal metabolism of tau, which accumulates as insoluble neuronal deposits. The adult human brain contains equal amounts of tau isoforms with three (3R) or four (4R) repeats of microtubule-binding domains, derived from the alternative splicing of exon 10 (E10) in the tau transcript. Several tauopathies are associated with imbalances of tau isoforms, due to splicing deficits. Here, we used a trans-splicing strategy to shift the inclusion of E10 in a mouse model of tauopathy that produces abnormal excess of 3R tau. Modulating the 3R/4R ratio in the prefrontal cortex led to a significant reduction of pathological tau accumulation concomitant with improvement of neuronal firing and reduction of cognitive impairments. Our results suggest promising potential for the use of RNA reprogramming in human neurodegenerative diseases.

9 July 2004 in Behavioural Brain Research
Verified
Journal Article
Closed access
MDM.A Delfino
M.A Delfino
ASA.V Stefano
A.V Stefano
JFJ.E Ferrario
J.E Ferrario
ITI.R.E Taravini
I.R.E Taravini
MMM.G Murer
M.G Murer
OGO.S Gershanik
O.S Gershanik

21 August 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JFJuan E. Ferrario
Juan E. Ferrario
PBPranetha Baskaran
Pranetha Baskaran
CCChristopher Clark
Christopher Clark
AHAenea Hendry
Aenea Hendry
OLOleg Lerner
Oleg Lerner
SGSarah Guthrie
Sarah Guthrie
Eye movements depend on correct patterns of connectivity between cranial motor axons and the extraocular muscles. Despite the clinical importance of the ocular motor system, little is known of the molecular mechanisms underlying its development. We have recently shown that mutations in the Chimaerin-1 gene encoding the signaling protein α2-chimaerin (α2-chn) perturb axon guidance in the ocular motor system and lead to the human eye movement disorder, Duane retraction syndrome (DRS). The axon guidance cues that lie upstream of α2-chn are unknown; here we identify candidates to be the Semaphorins (Sema) 3A and 3C, acting via the PlexinA receptors. Sema3A/C are expressed in and around the developing extraocular muscles and cause growth cone collapse of oculomotor neurons in vitro. Furthermore, RNAi knockdown of α2-chn or PlexinAs in oculomotor neurons abrogates Sema3A/C-dependent growth cone collapse. In vivo knockdown of endogenous PlexinAs or α2-chn function results in stereotypical oculomotor axon guidance defects, which are reminiscent of DRS, whereas expression of α2-chn gain-of-function constructs can rescue PlexinA loss of function. These data suggest that α2-chn mediates Sema3–PlexinA repellent signaling. We further show that α2-chn is required for oculomotor neurons to respond to CXCL12 and hepatocyte growth factor (HGF), which are growth promoting and chemoattractant during oculomotor axon guidance. α2-chn is therefore a potential integrator of different types of guidance information to orchestrate ocular motor pathfinding. DRS phenotypes can result from incorrect regulation of this signaling pathway.

16 August 2004 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
JFJuan E. Ferrario
Juan E. Ferrario
ITIrene R. E. Taravini
Irene R. E. Taravini
SMSophie Mourlevat
Sophie Mourlevat
ASAndrea Stefano
Andrea Stefano
MDMarina A. Delfino
Marina A. Delfino
OGOscar Gershanik
Oscar Gershanik

1 December 2008 in Behavioural Brain Research
Verified
Journal Article
Closed access
CLCelia Larramendy
Celia Larramendy
ITIrene R.E. Taravini
Irene R.E. Taravini
MSMariano D. Saborido
Mariano D. Saborido
JFJuan E. Ferrario
Juan E. Ferrario
MMMario G. Murer
Mario G. Murer
OGOscar S. Gershanik
Oscar S. Gershanik

20 February 2007 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
LGLaure Ginestet
Laure Ginestet
JFJuan E. Ferrario
Juan E. Ferrario
RRRita Raisman‐Vozari
Rita Raisman‐Vozari
EHEtienne C. Hirsch
Etienne C. Hirsch
TDThomas Debeir
Thomas Debeir